Intravenous ceftriaxone plus clindamycin reduces breast abscess formation in severe lactational mastitis
Abstract
Objective: Lactational mastitis can progress to local abscess formation if not treated promptly. The study aims to understand whether the use of intravenous cephalosporin plus clindamycin could reduce breast abscess formation when preferred as a first-line treatment instead of oral penicillin.
Method: Patients who admitted to our outpatient clinic with sign and symptoms of lactational mastitis were recruited retrospectively for the study. Patients who had abscess formation on admittance were excluded. Patients were categorized into two groups according to antibiotic preference as the group I with intravenous ceftriaxone plus clindamycin and group II with oral penicillin. Groups were compared according to abscess formation in follow-up by physical examination and ultrasound.
Results: A total of 64 patients with severe lactational mastitis were included. In group I (n=29), only one breast abscess with MSSA was developed. However, seven cases of breast abscess were developed in the second group (n=35). MRSA (n=4), MSSA (n=1), gram-negative bacilli (n=1) and no organism (n=1) were cultured in pus among group II. The prevalence of abscess in group I is found to be significantly lower in comparison to the control group in 12 weeks follow-up (p=0.049).
Conclusions: MRSA and gr (-) bacilli are the significant agents in persistent breast abscess formation, which are resistant to oral penicillin or first/second-line cephalosporin. The ceftriaxone plus clindamycin could be used to reduce abscess formation after severe lactational mastitis, therefore, avoids unnecessary operations and hospitalization.
Keywords
Kaynakça
- 1. Kinlay JR, O’Connell DL, Kinlay S. Incidence of mastitis in breastfeeding women during the six months after delivery: A prospective cohort study. Med J Aust. 1998;169(6):310–12.
- 2. Vogel A, Hutchison BL, Mitchell EA. Mastitis in the first year postpartum. Birth. 1999;26(4):218–25.
- 3. Fetherston C. Mastitis in lactating women: physiology or pathology? Breastfeed Rev. 2001;9(1):5–12.
- 4. Amir LH. ABM clinical protocol #4: Mastitis, revised in March 2014. Breastfeed Med. 2014;9(5):239–43.
- 5. Bolman M, Saju L, Oganesyan K, et al. Recapturing the art of therapeutic breast massage during breastfeeding. J Hum Lact. 2013;29(3):328–31.
- 6. Thomsen AC, Espersen T, Maigaard S. Course and treatment of milk stasis, noninfectious inflammation of the breast, and infectious mastitis in nursing women. Am J Obstet Gynecol. 1984;149(5):492–95.
- 7. Dener C, Inan A. Breast abscesses in lactating women. World J Surg. 2003;27(2):130–133.
- 8. Berens PD. Prenatal, intrapartum, and postpartum support of the lactating mother. Pediatr Clin North Am. 2001;48(2):365–375.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Araştırma Makalesi
Yayımlanma Tarihi
30 Eylül 2019
Gönderilme Tarihi
14 Haziran 2019
Kabul Tarihi
25 Eylül 2019
Yayımlandığı Sayı
Yıl 2019 Cilt: 41 Sayı: 3